Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.; No adverse event; Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.).    No concomitant medications were reported. Vial size was reported as 2.5mL.Vial was initially stored in the refrigerator on 18-Oct-2022.Vaccine use by date was 17-NOV-2022. Vial did not undergo any temperature excursions. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-675260:Patient 8 US-MODERNATX, INC.-MOD-2022-675238:Patient 1, same reporter US-MODERNATX, INC.-MOD-2022-675258:Patient 2, same reporter US-MODERNATX, INC.-MOD-2022-675259:Patient 3, same reporter US-MODERNATX, INC.-MOD-2022-675261:same reporter US-MODERNATX, INC.-MOD-2022-675262:same reporter US-MODERNATX, INC.-MOD-2022-675263:same reporter US-MODERNATX, INC.-MOD-2022-675265:same reporter US-MODERNATX, INC.-MOD-2022-675266:same reporter US-MODERNATX, INC.-MOD-2022-675268:same reporter US-MODERNATX, INC.-MOD-2022-675269:same reporter US-MODERNATX, INC.-MOD-2022-675270:same reporter US-MODERNATX, INC.-MOD-2022-675271:same reporter